BioNexus Gene Lab
BGLC
$0.60
Share price
3.21%
Change (1 day)
140.28%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Net assets
Net assets on the balance sheet as of December 2023 : $9.65 M
According to BioNexus Gene Lab's latest financial reports the company has $9.65 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
BioNexus Gene Lab - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $6.66 M | -7.17% |
| 2021-12-31 | $7.17 M | 7.77% |
| 2020-12-31 | $6.66 M | 493.58% |
| 2019-12-31 | $1.12 M | -26.25% |
| 2018-12-31 | $1.52 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 2,220.27% | 🇺🇸 USA |